Crop17 to support development of medical cannabis
The worldwide legal cannabis industry generated revenues in the region of £11.5bn in 2019 and is expected to grow to around £35bn by 2024. The potential margins from growing medical cannabis are more lucrative per gram for a grower than strawberries.
Crop17 is a new initiative to support the develop medical cannabis facilities, launched by Savills in partnership with Hanway Associates, a leading cannabis strategic consultancy and CambridgeHOK, an innovative glass-house builder.
17/02/2020